Jean-Sebastian Cournoyer
co-founder and Board Partner @ Real Ventures
Montréal, Canada
Jean-Sebastian Cournoyer is a seed investor at Real Ventures in Montréal focused on Software and Health Care. Jean-Sebastian Cournoyer is based out of Brossard, Quebec and is the co-founder and Board Partner of Real Ventures. Jean-Sebastian previously worked at TRU LUV as a Board. Jean-Sebastian Cournoyer attended Middlebury College.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Jean-Sebastian Cournoyer invests in
Stages Jean-Sebastian Cournoyer invests in
Countries Jean-Sebastian Cournoyer invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1M–$15M
- Series A
- $5M–$25M
- Series B
- $7.1M–$47M
Investment Focus
Industry
- Software 4 (17%)
- Health Care 4 (17%)
- Artificial Intelligence 4 (17%)
- Big Data 3 (13%)
- Cyber Security 3 (13%)
Stage
- Seed 8 (35%)
- Series A 5 (22%)
- Series B 4 (17%)
- Series C 2 (9%)
- Angel 1 (4%)
Country
- Canada 10 (43%)
- United States 2 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Founded in 2014, League is a technology-focused health company powering the digital transformation of healthcare. Employers, payers, pharmacy retailers and healthcare providers use our award-winning platform to deliver integrated and personalized health experiences that drive consumer engagement. Millions of people across the world use digitalhealth platforms powered by League to access, navigate and pay for care. | $95M / Series C / Dec 31, 2021 | ||
| Fletch is democratizing cybersecurity analytics by creating ready to go apps like the Fletch Trending Threats app that literally reads the threat news for companies daily telling them the threats that matter daily. | $15.8M / Series A / Jul 21, 2021 | ||
| Tenstorrent is enabling a new era in AI and deep learning with its breakthrough processor architecture and software. The company’s mission is to deliver orders of performance and efficiency for AI workloads from the data center to the edge of the Cloud by co-designing hardware, software, and AI algorithms with their technology.Tenstorrent’sarchitecture scales from datacenter servers to IoT devices with improved efficiency, flexibility, programmability compared to legacy accelerators including CPUs, GPUs, FPGAs, and TPU-type processors. It is developed by their team with expertise in computer architecture, hardware design and verification, systems engineering, compilers, software development, and machine learning algorithms.Tenstorrent is backed by Venture Capital firms including Real Ventures and Eclipse Venture Capital, as well as prominent industry luminaries. | $200M / Series C / May 20, 2021 | ||
| Delphia is building the world's first investment adviser that allows people to invest their data alongside their money in order to improve their investment returns. Delphia is able to forecast the growth and profitability for thousands of companies simultaneously through a series of machine learning models. When Delphia's modeldisagrees with the market, we adjust the weights of our diversified equity portfolio to reflect the confidence we have in our predictions. | $15.4M / Seed / Dec 04, 2019 | ||
| Acorn Biolabs is a healthcare technology company that provides access to the future of cell-based medicine through a non-invasive, follicle-based cell collection and cryopreservation service. Acorn Biolabs is cryopreserving people's healthy young cells for use in future regenerative treatments. Acorn Biolabs' services are available toconsumers directly through at-home and in-clinic collections and are available across Canada through a network of clinic and pharmacy partners. | $2.5M / Seed / Jan 11, 2019 | ||
| Plotly is a data science and AI company focused on taking data science out of the lab and into the business. Plotly makes it easy to create, deploy, and share interactive web apps, graphs, and visualizations in any programming language. | $7.1M / Series B / Nov 01, 2018 | ||
| Founded in 2014, League is a technology-focused health company powering the digital transformation of healthcare. Employers, payers, pharmacy retailers and healthcare providers use our award-winning platform to deliver integrated and personalized health experiences that drive consumer engagement. Millions of people across the world use digitalhealth platforms powered by League to access, navigate and pay for care. | $47.1M / Series B / Jul 24, 2018 | ||
| Delphia is building the world's first investment adviser that allows people to invest their data alongside their money in order to improve their investment returns. Delphia is able to forecast the growth and profitability for thousands of companies simultaneously through a series of machine learning models. When Delphia's modeldisagrees with the market, we adjust the weights of our diversified equity portfolio to reflect the confidence we have in our predictions. | $4.1M / Pre-Seed / Jun 13, 2018 | ||
| Busbud is a mobile app and platform that connects passengers to bus operators. It enables its users to search, compare, and book city-to-city bus tickets for any location and from any location. It is a comprehensive source of city-to-city bus schedules and tickets around the world, gathering schedules for over 10463 cities in 89 countries, in 10languages, and 15 currencies. The app offers a search tool allowing travelers to discover and plan their next bus trip.Busbud was founded by Michael Gradek, LP Maurice, and Frederic Thouin in October 2011. It is headquartered in Montreal City in Québec, Canada. | $11M / Series B / Jan 30, 2018 | ||
| Insight Engines empowers organizations to do deeply technical investigations of their data in minutes that today take days. Our first set of cyber security focused products are used daily by some of the largest healthcare, finance, and government organizations to go beyond their SIEM. (1) We automatically let them know the use cases that arepossible with the data in their log store, and what data they may want to remove. (2) We empower them to ask questions of their log data, via our unique natural language search technology, and get relevant answers in seconds. (3) We give them timely recommendations of what to ask. Our investors include folks like August Capital, Google Ventures, and DCVC. | $15.8M / Jul 20, 2017 | ||
| See all 23 investments → | |||
Co-Investors
About Real Ventures
Real Ventures is an early-stage venture firm focused on serving daring entrepreneurs with the ambition to create successful, global companies. Since 2007, Real Ventures has dedicated itself to building the Canadian startup ecosystem on the belief that people, not money, build game-changing companies. Real Ventures provides stage-specific guidance, mentorship, and access to networks and resources to fast-track founders’ personal and company growth. Real Ventures manages $325 million across five funds and its active portfolio of 100+ companies is currently valued at $10 billion. www.realventures.com
Real Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
John Stokes
Managing Partner
|
|||
Sam Haffar
Partner
|
|||
Alan MacIntosh
Partner and Co-Founder
|
|||
Craig Follett
Limited Partner (Investor)
|
|||
Hamzah Nassif
Executive
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Jean-Sebastian Cournoyer invest in?
Jean-Sebastian Cournoyer invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 23 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Jean-Sebastian Cournoyer invest in?
Jean-Sebastian Cournoyer typically joins rounds of $1M–$15M at Seed, $5M–$25M at Series A and $7.1M–$47M at Series B. These are whole funding-round sizes, not Jean-Sebastian Cournoyer's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Jean-Sebastian Cournoyer took part in.
How do I contact Jean-Sebastian Cournoyer?
Public channels for Jean-Sebastian Cournoyer include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jean-Sebastian Cournoyer last invest?
The most recent investment recorded for Jean-Sebastian Cournoyer closed in Dec 2021. Shizune tracks 23 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
